LINDSAY FRIED: Open Payments
NPI 1902312812 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 63 payments from 16 companies in 2025. Trend: 2023 $335 · 2024 $968 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $421 |
| PFIZER INC. | 15 | $253 |
| Astellas Pharma US Inc | 4 | $183 |
| Novo Nordisk Inc | 6 | $109 |
| Exact Sciences Corporation | 4 | $78 |
| Philips North America LLC | 3 | $75 |
| Dexcom, Inc. | 3 | $69 |
| Amgen Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
Products named: MOUNJARO, Veozah, PREVNAR 20, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across SC — which companies pay providers there.
